Literature DB >> 21667996

A switch I mutant of Cdc42 exhibits less conformational freedom.

Reena Chandrashekar1, Omar Salem, Hana Krizova, Robert McFeeters, Paul D Adams.   

Abstract

Cdc42 is a Ras-related small G-protein and functions as a molecular switch in signal transduction pathways linked with cell growth and differentiation. It is controlled by cycling between GTP-bound (active) and GDP-bound (inactive) forms. Nucleotide binding and hydrolysis are modulated by interactions with effectors and/or regulatory proteins. These interactions are centralized in two relatively flexible "Switch" regions as characterized by internal dynamics on multiple time scales [Loh, A. P., et al. (2001) Biochemistry 40, 4590-4600], and this flexibility may be essential for protein interactions. In the Switch I region, Thr(35) seems to be critical for function, as it is completely invariant in Ras-related proteins. To investigate the importance of conformational flexibility in Switch I of Cdc42, we mutated threonine to alanine, determined the solution structure, and characterized the backbone dynamics of the single-point mutant protein, Cdc42(T35A). Backbone dynamics data suggest that the mutation changes the time scale of the internal motions of several residues, with several resonances not being discernible in wild-type Cdc42 [Adams, P. D., and Oswald, R. E. (2007) Biomol. NMR Assignments 1, 225-227]. The mutation does not appear to affect the thermal stability of Cdc42, and chymotrypsin digestion data further suggest that changes in the conformational flexibility of Switch I slow proteolytic cleavage relative to that of the wild type. In vitro binding assays show less binding of Cdc42(T35A), relative to that of wild type, to a GTPase binding protein that inhibits GTP hydrolysis in Cdc42. These results suggest that the mutation of T(35) leads to the loss of conformational freedom in Switch I that could affect effector-regulatory protein interactions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21667996      PMCID: PMC3134622          DOI: 10.1021/bi2004284

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  55 in total

1.  Efficient analysis of macromolecular rotational diffusion from heteronuclear relaxation data.

Authors:  P Dosset; J C Hus; M Blackledge; D Marion
Journal:  J Biomol NMR       Date:  2000-01       Impact factor: 2.835

2.  A distinct class of dominant negative Ras mutants: cytosolic GTP-bound Ras effector domain mutants that inhibit Ras signaling and transformation and enhance cell adhesion.

Authors:  James J Fiordalisi; Stephen P Holly; Ronald L Johnson; Leslie V Parise; Adrienne D Cox
Journal:  J Biol Chem       Date:  2002-01-17       Impact factor: 5.157

3.  Isolation and characterization of effector-loop mutants of CDC42 in yeast.

Authors:  A S Gladfelter; J J Moskow; T R Zyla; D J Lew
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

4.  Antiapoptotic Cdc42 mutants are potent activators of cellular transformation.

Authors:  Shine S Tu; Wen Jin Wu; Wannian Yang; Peri Nolbant; Klaus Hahn; Richard A Cerione
Journal:  Biochemistry       Date:  2002-10-15       Impact factor: 3.162

5.  Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.

Authors:  Yuan Gao; J Bradley Dickerson; Fukun Guo; Jie Zheng; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

6.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

7.  ARAP3 inhibits peritoneal dissemination of scirrhous gastric carcinoma cells by regulating cell adhesion and invasion.

Authors:  R Yagi; M Tanaka; K Sasaki; R Kamata; Y Nakanishi; Y Kanai; R Sakai
Journal:  Oncogene       Date:  2010-11-15       Impact factor: 9.867

8.  Dynamic properties of the Ras switch I region and its importance for binding to effectors.

Authors:  M Spoerner; C Herrmann; I R Vetter; H R Kalbitzer; A Wittinghofer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

9.  Backbone dynamics of an oncogenic mutant of Cdc42Hs shows increased flexibility at the nucleotide-binding site.

Authors:  Paul D Adams; Adrienne P Loh; Robert E Oswald
Journal:  Biochemistry       Date:  2004-08-10       Impact factor: 3.162

10.  The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase.

Authors:  Ralf Schmidmaier; Philipp Baumann; Meral Simsek; Farshid Dayyani; Bertold Emmerich; Gerold Meinhardt
Journal:  Blood       Date:  2004-05-25       Impact factor: 22.113

View more
  5 in total

1.  Intrinsic GTP hydrolysis is observed for a switch 1 variant of Cdc42 in the presence of a specific GTPase inhibitor.

Authors:  Kyla M Morris; Rory Henderson; Thallapuranam Krishnaswamy Suresh Kumar; Colin D Heyes; Paul D Adams
Journal:  Small GTPases       Date:  2016-02-01

2.  Optimization and stabilization of Rho small GTPase proteins for solution NMR studies: The case of Rnd1.

Authors:  Shufen Cao; Matthias Buck
Journal:  Small GTPases       Date:  2011-11-01

3.  Prospective Development of Small Molecule Targets to Oncogenic Ras Proteins.

Authors:  Reena Chandrashekar; Paul D Adams
Journal:  Open J Biophys       Date:  2013-10-01

Review 4.  Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates.

Authors:  Xing-Hua Xiao; Lin-Chen Lv; Jing Duan; Ye-Meng Wu; Shu-Jin He; Zhen-Zhen Hu; Li-Xia Xiong
Journal:  Molecules       Date:  2018-03-29       Impact factor: 4.411

5.  Active and Inactive Cdc42 Differ in Their Insert Region Conformational Dynamics.

Authors:  Nurit Haspel; Hyunbum Jang; Ruth Nussinov
Journal:  Biophys J       Date:  2020-12-19       Impact factor: 4.033

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.